Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)
Eur Urol Oncol 2021 Sep 03;[EPub Ahead of Print], JN Staffurth, JS Haviland, A Wilkins, I Syndikus, V Khoo, D Bloomfield, C Parker, J Logue, C Scrase, A Birtle, Z Malik, M Panades, C Eswar, J Graham, M Russell, C Ferguson, JM O'Sullivan, CA Cruickshank, D Dearnaley, E HallFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.